Notice Title

Consent to the Distribution of New Medicines

Publication Date
22 Sep 2022

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2022-go3979
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Repatha
Active Ingredient: Evolocumab 140mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Amgen New Zealand Limited
Manufacturer: Amgen Manufacturing Limited, Juncos, Puerto Rico
   
Product: Repatha (SureClick)
Active Ingredient: Evolocumab 140mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Amgen New Zealand Limited
Manufacturer: Amgen Manufacturing Limited, Juncos, Puerto Rico


Dated this 16th day of September 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).